Year | No. of studies | Sample size (Total) | HBV prevalence % (95 CI) | I2 (%) |
---|---|---|---|---|
PWID | ||||
 ≤ 2003 | 7 | 84 | 5.8 (3.5–9.4) | 2 |
2004–2006 | 4 | 2093 | 8.2 (3.9–16.5) | 2 |
2007–2009 | 8 | 2231 | 4.4 (3.7–5.4) | 0 |
2010–2012 | 7 | 1682 | 3.9 (1.9–7.9) | 9 |
2013–2015 | 4 | 845 | 2.7 (1.8–4.1) | 0 |
 ≥ 2016 | 3 | 1434 | 3.1 (2.3–4.1) | 0 |
Non-injecting PWUD | ||||
 ≤ 2003 | 1 | 149 | 1.3 (0.3–5.2) | − |
2004–2006 | 3 | 430 | 3.3 (1.9–5.4) | 0 |
2007–2009 | 2 | 539 | 3.0 (1.8–4.8) | 0 |
2010–2012 | 2 | 252 | 1.2 (0.4–3.6) | 0 |
2013–2015 | 2 | 3539 | 2.8 (2.3–3.4) | 0 |
 ≥ 2016 | 1 | 3917 | 3.0 (2.6–3.6) | − |